Reimagining Medicine slide image

Reimagining Medicine

Company overview Financial review 2023 priorities Appendix Vas Narasimhan, M.D. Chief Executive Officer 46 Investor Relations | Q4 2022 Results NOVARTIS | Reimagining Medicine
View entire presentation